Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

XFOR

X4 Pharmaceuticals, Inc

CIK 0001501697 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$4.04
↑ 0.01 (0.25%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Excluded: Options (no data)

Key stats

Market Cap
$400.55M
P/E Ratio
-4.44
EPS
-1.87
Dividend Yield
Not covered
52W Position
63%
Beta
1.92

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.58
P/S
45.75
EV/Revenue
32.03
ROE
-58.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 63%
$2.71$4.83

Latest Financials

2025-12-31 FY
Revenue
$6.50M
Net Income
-$79.20M
Total Assets
$290.46M
Free Cash Flow
–

Recent news